EVLO - エベロ・バイオサイエンシズ (Evelo Biosciences Inc.) エベロ・バイオサイエンシズ

 EVLOのチャート


 EVLOの企業情報

symbol EVLO
会社名 Evelo Biosciences Inc (エベロ・バイオサイエンシズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 Evelo Biosciences Inc. is engaged in developing therapies designed to act on gut-body network. The Company develops monoclonal microbes that are orally-delivered compositions of specific strains of naturally occurring microbes derived from a single clone. Its principal product candidates include EDP1066 EDP1815 and EDP1503 that are in the pre-clinical development stage. EDP1066 and EDP1815 are monoclonal microbial product candidates that are developed to treat inflammatory diseases that include psoriasis atopic dermatitis rheumatoid arthritis and ulcerative colitis. EDP1503 is the Company's product candidate developed under oncology portfolio to treat diseases such as colorectal cancer renal cell carcinoma and melanoma among others.   エベロ・バイオサイエンシズは米国のバイオ医薬品企業。主にマイクロバイオ―ムによる、がん、自己免疫および炎症性疾患に対する免疫療法の開発に従事する。同社は、がん治療のためのオンコマイシンを開発。また、アトピ―性皮膚炎、関節リウマチ、潰瘍性大腸炎、結腸直腸がん、腎細胞がん、メラノ―マなどの免疫療法に焦点を当てる。本社所在地はマサチュ―セッツ州ケンブリッジ。   Evelo Biosciences is a clinical stage biotechnology company developing orally delivered product candidates that are designed to act on the small intestinal axis, SINTAX™, with systemic therapeutic effects. SINTAX plays a central role in governing the immune, metabolic, and neurological systems. The Company's first product candidates are pharmaceutical preparations of single strains of microbes selected for the potential to offer defined pharmacological properties. Evelo's therapies have the potential to be effective, safe, and affordable medicines to improve the lives of people with inflammatory diseases and cancer.
本社所在地 620 Memorial Drive Suite 200 Cambridge MA 02139 USA
代表者氏名 Noubar B. Afeyan Noubar B. Afeyan
代表者役職名 Chairman of the Board 取締役会会長
電話番号 +1 617-870-8281
設立年月日 41760
市場名 NASDAQ National Market System
ipoyear 2018年
従業員数 59人
url www.evelobio.com
nasdaq_url https://www.nasdaq.com/symbol/evlo
adr_tso
EBITDA EBITDA(百万ドル) ー
終値(lastsale) 11.65
時価総額(marketcap) 369789663.3
時価総額 時価総額(百万ドル) 360.26720
売上高 売上高(百万ドル) --
企業価値(EV) 企業価値(EV)(百万ドル) 196.11820
当期純利益 当期純利益(百万ドル) --
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Evelo Biosciences Inc revenues was not reported. Net loss applicable to common stockholders increased from $14.4M to $29.6M. Higher net loss reflects Research and development - Balancing increase of 96% to $16.3M (expense) General and administrative - Balancing increase from $2.6M to $6.4M (expense) Stock-based Compensation in SGA increase from $256K to $1.9M (expense).

 EVLOのテクニカル分析


 EVLOのニュース

   Evelo Biosciences GAAP EPS of -$0.28 in-line  2022/11/15 13:47:12 Seeking Alpha
Evelo Biosciences press release (EVLO): Q3 GAAP EPS of -$0.28 in-line.As of September 30, 2022, cash and cash equivalents were $69.1M, as compared to cash and cash equivalents of…
   Evelo Biosciences Reports Third Quarter 2022 Financial Results and Business Highlights  2022/11/14 22:27:00 GlobeNewswire
- Multiple Phase 2 readouts for EDP1815 in atopic dermatitis expected in 2023; data from first three cohorts expected in early 1Q 2023 and fourth cohort in 2Q 2023 -
   Have you been able to find a good deal on Evelo Biosciences Inc.’s shares?  2022/09/19 15:48:00 US Post News
The share price of Evelo Biosciences Inc. (NASDAQ:EVLO) fell to $2.11 per share on Friday from $2.12. While Evelo Biosciences Inc. has underperformed by -0.47%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, EVLO fell by -71.14%, with highs and lows ranging from $12.74 to $1.42, […]
   Evelo Biosciences (EVLO) Investor Presentation - Slideshow (NASDAQ:EVLO)  2022/09/16 22:15:36 Seeking Alpha
The following slide deck was published by Evelo Biosciences, Inc.
   Do investors need to be concerned about Evelo Biosciences Inc. (EVLO)?  2022/09/05 15:40:00 US Post News
As of Friday, Evelo Biosciences Inc.’s (NASDAQ:EVLO) stock closed at $2.41, up from $2.29 the previous day. While Evelo Biosciences Inc. has overperformed by 5.47%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, EVLO fell by -78.60%, with highs and lows ranging from $12.74 to $1.42, […]
   Evelo Biosciences GAAP EPS of -$0.28 in-line  2022/11/15 13:47:12 Seeking Alpha
Evelo Biosciences press release (EVLO): Q3 GAAP EPS of -$0.28 in-line.As of September 30, 2022, cash and cash equivalents were $69.1M, as compared to cash and cash equivalents of…
   Evelo Biosciences Reports Third Quarter 2022 Financial Results and Business Highlights  2022/11/14 22:27:00 GlobeNewswire
- Multiple Phase 2 readouts for EDP1815 in atopic dermatitis expected in 2023; data from first three cohorts expected in early 1Q 2023 and fourth cohort in 2Q 2023 -
   Have you been able to find a good deal on Evelo Biosciences Inc.’s shares?  2022/09/19 15:48:00 US Post News
The share price of Evelo Biosciences Inc. (NASDAQ:EVLO) fell to $2.11 per share on Friday from $2.12. While Evelo Biosciences Inc. has underperformed by -0.47%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, EVLO fell by -71.14%, with highs and lows ranging from $12.74 to $1.42, […]
   Evelo Biosciences (EVLO) Investor Presentation - Slideshow (NASDAQ:EVLO)  2022/09/16 22:15:36 Seeking Alpha
The following slide deck was published by Evelo Biosciences, Inc.
   Do investors need to be concerned about Evelo Biosciences Inc. (EVLO)?  2022/09/05 15:40:00 US Post News
As of Friday, Evelo Biosciences Inc.’s (NASDAQ:EVLO) stock closed at $2.41, up from $2.29 the previous day. While Evelo Biosciences Inc. has overperformed by 5.47%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, EVLO fell by -78.60%, with highs and lows ranging from $12.74 to $1.42, […]
   Have you been able to find a good deal on Evelo Biosciences Inc.’s shares?  2022/09/19 15:48:00 US Post News
The share price of Evelo Biosciences Inc. (NASDAQ:EVLO) fell to $2.11 per share on Friday from $2.12. While Evelo Biosciences Inc. has underperformed by -0.47%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, EVLO fell by -71.14%, with highs and lows ranging from $12.74 to $1.42, […]
   Evelo Biosciences (EVLO) Investor Presentation - Slideshow (NASDAQ:EVLO)  2022/09/16 22:15:36 Seeking Alpha
The following slide deck was published by Evelo Biosciences, Inc.
   Do investors need to be concerned about Evelo Biosciences Inc. (EVLO)?  2022/09/05 15:40:00 US Post News
As of Friday, Evelo Biosciences Inc.’s (NASDAQ:EVLO) stock closed at $2.41, up from $2.29 the previous day. While Evelo Biosciences Inc. has overperformed by 5.47%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, EVLO fell by -78.60%, with highs and lows ranging from $12.74 to $1.42, […]
   Buying the Dip: Here are Top 5 Stocks Hedge Funds Bought the Most  2022/08/22 08:08:18 TipRanks
Hedge funds are known for beating the average market returns. Thus, keeping a tab on which stocks hedge funds are buying becomes important. With several top stocks trading at a significant discount from their highs, let’s leverage TipRanks’ Hedge Fund Trading Activity tool (it uses data from Form 13-F to offer hedge fund signals) to look at the top five stocks that hedge fund managers bought the most in the last three months. Top 5 Most Bought Stocks Evelo Biosciences (NASDAQ:EVLO) Rank: #5 Number of Shares Bought By Hedge Funds: 27.4M Evelo Biosciences is a clinical-stage biotech company focused on developing orally delivered products for treating inflammatory diseases and cancer.
   Evelo Biosciences Inc PT Lowered to $5 at Chardan Capital Markets  2022/08/15 12:19:02 Investing.com
https://www.investing.com/news/pro/evelo-biosciences-inc-pt-lowered-to-5-at-chardan-capital-markets-432SI-2872570

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 エベロ・バイオサイエンシズ EVLO Evelo Biosciences Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)